المؤلفون: Gil García, Yudith Lorena, Serrano Ortíz, Ivonne Alexandra, López Martínez, Angie Dayanna, Valderrama Sanchez, Angie Stephanie

المساهمون: Contreras Ramos, Luz Mery

مصطلحات موضوعية: Adherencia y Cumplimiento del Tratamiento, Anticarcinógenos, Neoplasia de la Mama, Mujeres, 2022ENF47126, Adherence and compliance to treatment, Anticarcinogens, Breast neoplasia, Women

وصف الملف: 80 p.; application/pdf

Relation: Ahmed Elsamany, S., Alghanmi, H., Albaradei, A., Abdelhamid, R., Madi, E., & Ramzan, A. (2022). Assessment of compliance with hormonal therapy in early breast cancer patients with positive hormone receptor phenotype: A single institution study. The Breast, 62(1), 69-74. https://doi.org/10.1016/j.breast.2022.01.017; Aiello Bowles, E. J., Boudreau, D. M., Chubak, J., Yu, O., Fujii, M., Chestnut, J., & Buist, D. S. M. (2012). Patient-Reported Discontinuation of Endocrine Therapy and Related Adverse Effects Among Women With Early-Stage Breast Cancer. Journal of Oncology Practice, 8(6), e149-e157. https://doi.org/10.1200/JOP.2012.000543; American Brain Tumor Association. (2018). Quimioterapia. abta.org. https://www.abta.org/wp-content/uploads/2018/03/quimioterapia.pdf; American Cancer Society. (2019a). Biopsia del seno. cancer.org. https://www.cancer.org/es/cancer/cancer-de-seno/pruebas-de-deteccion-y-deteccion-temprana-del-cancer-de-seno/biopsia-del-seno.html; American Cancer Society. (2019b). Inmunoterapia. cancer.org. https://www.cancer.org/es/tratamiento/tratamientos-y-efectos-secundarios/tipos-de-tratamiento/inmunoterapia.html; American Cancer Society. (2019c). Radioterapia interna (braquiterapia). cancer.org. https://www.cancer.org/es/tratamiento/tratamientos-y-efectos-secundarios/tipos-de-tratamiento/radioterapia/radioterapia-interna.html; American Cancer Society. (2019d). Tratamiento del cáncer de seno. cancer.org. https://www.cancer.org/es/cancer/cancer-de-seno/tratamiento.html; Angarita, J. R. Q. (2007). Teoría de las Necesidades de Maslow. DocPlayer, 1(1), 1-6. https://docplayer.es/20908893-Teoria-de-las-necesidades-de-maslow.html; Atkins, L., & Fallowfield, L. (2006). Intentional and non-intentional non-adherence to medication amongst breast cancer patients. European Journal of Cancer, 42(14), 2271-2276. https://doi.org/10.1016/j.ejca.2006.03.004; Barsha, N. A., Rahman, A., & Mahdy, M. R. C. (2021). Automated detection and grading of Invasive Ductal Carcinoma breast cancer using ensemble of deep learning models. Computers in Biology and Medicine, 139(1), 1-9. https://doi.org/10.1016/j.compbiomed.2021.104931; Bautista, N. (2020). Detecte el cáncer de mama a tiempo. Minsalud. https://www.minsalud.gov.co/Paginas/Detecte-el-cancer-de-mama-a-tiempo.aspx; Berkowitz, M. J., Thompson, C. K., Zibecchi, L. T., Lee, M. K., Streja, E., Berkowitz, J. S., Wenziger, C. M., Baker, J. L., DiNome, M. L., & Attai, D. J. (2021). How patients experience endocrine therapy for breast cancer: An online survey of side effects, adherence, and medical team support. Journal of Cancer Survivorship, 15(1), 29-39. https://doi.org/10.1007/s11764-020-00908-5; Boussen, H., Labidi, S., Mejri, N., Belaid, A., Bouzaiene, H., El Benna, H., Afrit, M., Gamoudi, A., Hemissa, S., Benna, F., Rahal, K., Gligorov, J., & Belkacemi, Y. (2017). Cáncer de mama inflamatorio. EMC - Ginecología-Obstetricia, 53(1), 1-9. https://doi.org/10.1016/S1283-081X(16)82413-3; Breastcancer. (2017, abril 20). Factores de riesgo del cáncer de mama. Breastcancer.org. https://www.breastcancer.org/es/sintomas/cancer_de_mama/riesgo/factores; Briceño, I., Gómez Gutiérrez, A., Díaz Dussán, N. A., Noguera Santamaría, M. C., Díaz Rincón, D., & Casas Gómez, M. C. (2017). Mutational spectrum in breast cancer associated BRCA1 and BRCA2 genes in Colombia. Colombia Medica, 48(2), 12-16. https://doi.org/10.25100/cm.v48i2.1867; Brito, C., Portela, M. C., & de Vasconcellos, M. T. L. (2014). Adherence to hormone therapy among women with breast cancer. BMC Cancer, 14(1), 397. https://doi.org/10.1186/1471-2407-14-397; Cahir, C., Barron, T. I., Sharp, L., & Bennett, K. (2017). Can demographic, clinical and treatment-related factors available at hormonal therapy initiation predict non-persistence in women with stage I–III breast cancer? Cancer Causes and Control, 28(3), 215-225. https://doi.org/10.1007/s10552-017-0851-9; CancerHelp. (2017). Estadios del cáncer de mama. CancerHelp Institute. http://cancerhelpessentiahealth.org/Cancer_Types_Spanish/breast_200013S1_02.html; Casciato, D., & Territo, M. (2013). Manual de Oncología Clínica (7.a ed.). Lippincott Williams & Wilkins. https://bbibliograficas.ucc.edu.co:2280/es/ereader/ucc/125327?page=303; Cavazza, M., Banks, H., Ercolanoni, M., Cukaj, G., Bianchi, G., Capri, G., & Longo, F. (2020). Factors influencing adherence to adjuvant endocrine therapy in breast cancer-treated women: Using real-world data to inform a switch from acute to chronic disease management. Breast Cancer Research and Treatment, 183(1), 189-199. https://doi.org/10.1007/s10549-020-05748-6; Cheung, W. Y., Lai, E. C.-C., Ruan, J. Y., Chang, J. T., & Setoguchi, S. (2015). Comparative adherence to oral hormonal agents in older women with breast cancer. Breast Cancer Research and Treatment, 152(2), 419-427. https://doi.org/10.1007/s10549-015-3455-7; Cluze, C., Rey, D., Huiart, L., BenDiane, M. K., Bouhnik, A. D., Berenger, C., Carrieri, M. P., & Giorgi, R. (2012). Adjuvant endocrine therapy with tamoxifen in young women with breast cancer: Determinants of interruptions vary over time. Annals of Oncology, 23(4), 882-890. https://doi.org/10.1093/annonc/mdr330; Degu, A., & Kebede, K. (2020). Drug-related problems and its associated factors among breast cancer patients at the University of Gondar Comprehensive Specialized Hospital, Ethiopia: A hospital-based retrospective cross-sectional study: Journal of Oncology Pharmacy Practice, 27(1), 88-98. https://doi.org/10.1177/1078155220914710; Díaz, J., Ruibal Morell, Á., & Tejerina, A. (2012). Cáncer de mama: Aspectos de interés actual (1.a ed.). Ademas Comunicación Gráfica. https://www.master-mastologia.com/wp-content/uploads/2014/07/DOCUMENTO-PDF-LIBRO-FEMA-web.pdf; Farias, A. J., & Du, X. L. (2017). Association Between Out-Of-Pocket Costs, Race/Ethnicity, and Adjuvant Endocrine Therapy Adherence Among Medicare Patients With Breast Cancer. Journal of Clinical Oncology, 35(1), 86-95. https://doi.org/10.1200/JCO.2016.68.2807; Fernández, Á., & Reigosa, A. (2016). Cáncer de mama hereditario. Comunidad y Salud, 14(1), 52-60. http://ve.scielo.org/pdf/cs/v14n1/art08.pdf; Fink, A. K., Gurwitz, J., Rakowski, W., Guadagnoli, E., & Silliman, R. A. (2004). Patient Beliefs and Tamoxifen Discontinuance in Older Women With Estrogen Receptor—Positive Breast Cancer. Journal of Clinical Oncology, 22(16), 3309-3315. https://doi.org/10.1200/JCO.2004.11.064; Gaitán, D. B., & Amaya, C. F. R. (2018). Estudio de consumo y Reacciones Adversas a Tamoxifeno en Colombia en el Periodo 2010-2015 [Facultad de Ciencias, Universidad de Ciencias Aplicadas y Ambientales].https://repository.udca.edu.co/bitstream/handle/11158/1110/ESTUDIO%20DE%20CONSUMO%20Y%20REACCIONES%20ADVERSAS%20A%20TAMOXIFENO%20EN%20COLOMBIA%20EN%20EL%20PERIODO%202010-2015.pdf?sequence=1&isAllowed=y; Gallups, S. F., Connolly, M. C., Bender, C. M., & Rosenzweig, M. Q. (2018). Predictors of Adherence and Treatment Delays among African American Women Recommended to Receive Breast Cancer Chemotherapy. Women’s Health Issues, 28(6), 553-558. https://doi.org/10.1016/j.whi.2018.08.001; García, J., González, S., Gascón, A., Hernández, L., Barrera, F., & Lavín, R. (2016). Lesiones BIRADS 3 y 4 vistas por ultrasonido y no vistas por mamografía digital y tomosíntesis. Anales de Radiología México, 15(3), 205-213. https://www.webcir.org/revistavirtual/articulos/2017/4_noviembre/mx/lesiones_esp.pdf; García-Reza, C., López, M. L., Zeitoune, R. C. G., Solano-Solano, G., Ávila, L. A., & Pilar, M. M. D. (2012). Rol socioeconómico y la adhesión al tratamiento de pacientes con hipertensión arterial—Contribución de enfermería. Revista Cuidarte, 3(1), 1-7. https://doi.org/10.15649/cuidarte.v3i1.22; Garrido, E. (2016). Neoplasia de mama (1.a ed., Vol. 1). El Cid Editor. https://bbibliograficas.ucc.edu.co:2280/es/ereader/ucc/27607?page=1; Gonzalez, F., Zuluaga-Liberato, A., Lopez-Correa, P., Velasquez, J. C., Gonzalez, C. B., Sánchez-Castillo, O., Cervera-Bonilla, S., Bruges, R., Contreras-Mejía, F., Guzman-Abisaab, L., Lehmann-Mosquera, C., Garcia-Mora, M., Angel-Aristizabal, J., Duarte, C., & Casas, S. E. D. (2021). Manejo sistémico adyuvante en pacientes con cáncer de mama y enfermedad residual invasiva posterior a quimioterapia neoadyuvante. Actualización de la Evidencia y Abordaje Terapéutico en el Instituto Nacional de Cancerología, Bogotá-Colombia. Revista Colombiana de Cancerología, 25(1), 160-166. https://doi.org/10.35509/01239015.745; Guedes, J. B. R., Guerra, M. R., Alvim, M. M., & Leite, I. C. G. (2017). Factors associated with adherence and persistence to hormonal therapy in women with breast cancer [Fatores associados à adesão e à persistência na hormonioterapia em mulheres com câncer de mama]. Revista Brasileira de Epidemiologia, 20(4), 636-649. https://doi.org/10.1590/1980-5497201700040007; He, W., Eriksson, L., Törnberg, S., Strand, F., Hall, P., & Czene, K. (2019). Discontinuation of adjuvant hormone therapy among breast cancer patients not previously attending mammography screening. BMC Medicine, 17(1), 24. https://doi.org/10.1186/s12916-019-1252-6; He, W., Fang, F., Varnum, C., Eriksson, M., Hall, P., & Czene, K. (2015). Predictors of Discontinuation of Adjuvant Hormone Therapy in Patients With Breast Cancer. Journal of Clinical Oncology, 33(20), 2262-2269. https://doi.org/10.1200/JCO.2014.59.3673; Hernández, Á. H. C. (2015). Calidad de vida y adherencia al tratamiento de personas con enfermedad crónica oncológica. Revista Cuidarte, 6(1), 906-913. https://doi.org/10.15649/cuidarte.v6i1.146; Herrera, Á., Ñamendys, S., & Meneses, A. (2017). Manual de Oncología: Procedimientos medico quirúrgicos (F. Valenzuela & M. Bernal, Eds.; 6.a ed.). McGraw-Hill Interamericana Editores, S. A. de C.V. https://bbibliograficas.ucc.edu.co:2308/stage.aspx?il=5217&pg=&ed=; Herrera, M. P. J. (2019). Informe de evento cáncer de mama y cuello uterino en colombia, 2018 (Informe de evento N.o 4; pp. 2-15). Instituto Nacional de Salud. https://www.ins.gov.co/buscador-eventos/Informesdeevento/C%C3%81NCER%20DE%20MAMA%20Y%20CUELLO%20UTERINO_2018.pdf; Hershman, D. L., Kushi, L. H., Hillyer, G. C., Coromilas, E., Buono, D., Lamerato, L., Bovbjerg, D. H., Mandelblatt, J. S., Tsai, W.-Y., Zhong, X., Jacobson, J. S., Wright, J. D., & Neugut, A. I. (2016). Psychosocial Factors Related to Non-persistence with Adjuvant Endocrine Therapy among Women with Breast Cancer: The Breast Cancer Quality of Care Study (BQUAL). Breast cancer research and treatment, 157(1), 133-143. https://doi.org/10.1007/s10549-016-3788-x; Hershman, D. L., Kushi, L. H., Shao, T., Buono, D., Kershenbaum, A., Tsai, W.-Y., Fehrenbacher, L., Lin Gomez, S., Miles, S., & Neugut, A. I. (2010). Early Discontinuation and Nonadherence to Adjuvant Hormonal Therapy in a Cohort of 8,769 Early-Stage Breast Cancer Patients. Journal of Clinical Oncology, 28(27), 4120-4128. https://doi.org/10.1200/JCO.2009.25.9655; Hsieh, K.-P., Chen, L.-C., Cheung, K.-L., & Yang, Y.-H. (2015). Risks of nonadherence to hormone therapy in Asian women with breast cancer. The Kaohsiung Journal of Medical Sciences, 31(6), 328-334. https://doi.org/10.1016/j.kjms.2015.04.002; Huiart, L., Bouhnik, A.-D., Rey, D., Tarpin, C., Cluze, C., Bendiane, M. K., Viens, P., & Giorgi, R. (2012). Early discontinuation of tamoxifen intake in younger women with breast cancer: Is it time to rethink the way it is prescribed? European Journal of Cancer, 48(13), 1939-1946. https://doi.org/10.1016/j.ejca.2012.03.004; Instituto Nacional del Cáncer. (2021, octubre 25). Terapias dirigidas contra el cáncer—Instituto Nacional del Cáncer (nciglobal,ncienterprise) [CgvArticle]. cancer.gov. https://www.cancer.gov/espanol/cancer/tratamiento/tipos/terapia-dirigida/hoja-informativa-terapias-dirigidas; Jacob Arriola, K. R., Mason, T. A., Bannon, K. A., Holmes, C., Powell, C. L., Horne, K., & O’Regan, R. (2014). Modifiable risk factors for adherence to adjuvant endocrine therapy among breast cancer patients. Patient Education and Counseling, 95(1), 98-103. https://doi.org/10.1016/j.pec.2013.12.019; Kemp, A., Preen, D. B., Saunders, C., Boyle, F., Bulsara, M., Malacova, E., & Roughead, E. E. (2014). Early discontinuation of endocrine therapy for breast cancer: Who is at risk in clinical practice? SpringerPlus, 3(1), 282. https://doi.org/10.1186/2193-1801-3-282; Kroenke, C. H., Hershman, D. L., Gomez, S. L., Adams, S. R., Eldridge, E. H., Kwan, M. L., Ergas, I. J., Kubo, A., & Kushi, L. H. (2018). Personal and clinical social support and adherence to adjuvant endocrine therapy among hormone receptor-positive breast cancer patients in an integrated health care system. Breast Cancer Research and Treatment, 170(3), 623-631. https://doi.org/10.1007/s10549-018-4774-2; Lee, J. Y., & Min, Y. H. (2018). Relationships between determinants of adjuvant endocrine therapy adherence in breast cancer. BMC Women’s Health, 18(1), 48. https://doi.org/10.1186/s12905-018-0522-3; Majlis D, S. (2008). FEMALE HORMONES AND BREAST CÁNCER: CONTROVERSIES AND EVIDENCES AT 2008. WHAT TO ANSWER TO OUR PATIENTS? Revista chilena de radiología, 14(3), 113-121. https://doi.org/10.4067/S0717-93082008000300003; Martínez, A. E., Lozano, A., Rodríguez, A. L., Galindo, Ó., & Alvarado, S. (2014). Impacto psicológico del cáncer de mama y la mastectomía. Gaceta Mexicana de Oncología, 13(1), 53-58. https://www.elsevier.es/es-revista-gaceta-mexicana-oncologia-305-articulo-impacto-psicologico-del-cancer-mama-X1665920114278797; Mathelin, C., Antoni, D., Lodi, M., Chenard, M.-P., & Molière, S. (2021). Carcinoma ductal in situ. EMC - Ginecología-Obstetricia, 57(1), 1-12. https://doi.org/10.1016/S1283-081X(20)44698-3; McCart Reed, A. E., Kalinowski, L., Simpson, P. T., & Lakhani, S. R. (2021). Invasive lobular carcinoma of the breast: The increasing importance of this special subtype. Breast Cancer Research, 23(1), 1-16. https://doi.org/10.1186/s13058-020-01384-6; Minh, L. D., Quang, B. V., Mai, D. N. L., Quyen, L. L., Gia, N. H., Hang, N. T., & Giang, K. B. (2022). Health Literacy of Newly-Admitted Cancer Patients in Vietnam: Difficulties Understanding Treatment Options and Processing Health-Related Information: Health Services Insights, 15(1), 1-10. https://doi.org/10.1177/11786329211067325; Ministerio de Salud. (s. f.). Cáncer de mama. Minsalud. Recuperado 17 de noviembre de 2021, de https://www.minsalud.gov.co/salud/publica/ssr/Paginas/Cancer-de-mama.aspx Resolución 8430 de 1993—Colombia, Pub. L. No. 8430, 1 (1993). https://www.minsalud.gov.co/sites/rid/Lists/BibliotecaDigital/RIDE/DE/DIJ/RESOLUCION-8430-DE-1993.PDF; Miñambres, R., Pita Macpherson, G., Sánchez Guiu, M. I., Serra Esteve, D., Rosa Ferrero, R., Rubio Solsona, E., Palacios Gil-Antuñano, S., Llaneza-Folgueras, A., Marrón, P. I., Hoyas Calvo, S., Lluch Hernández, A., Cano Sánchez, A., Gonzalez-Neira, A., Triviño Pardo, J. C., & Benítez Ortiz, J. (2019). Predicción de riesgo de cáncer de mama en mujeres sanas de población española basado en el estudio de variantes genéticas. Revista de Senología y Patología Mamaria, 32(3), 94-99. https://doi.org/10.1016/j.senol.2019.07.001; Nadrljanski, M. M., & Milosevic, Z. C. (2020). Tumor texture parameters of invasive ductal breast carcinoma in neoadjuvant chemotherapy: Early identification of non-responders on breast MRI. Clinical Imaging, 65(1), 119-123. https://doi.org/10.1016/j.clinimag.2020.04.016; Neugut, A. I., Zhong, X., Wright, J. D., Accordino, M., Yang, J., & Hershman, D. L. (2016). Nonadherence to Medications for Chronic Conditions and Nonadherence to Adjuvant Hormonal Therapy in Women With Breast Cancer. JAMA Oncology, 2(10), 1326-1332. https://doi.org/10.1001/jamaoncol.2016.1291; Olivera-Fernandez, R., Fernández-Ribeiro, F., Piñeiro-Corrales, G., & Crespo-Diz, C. (2014). Adherence to oral antineoplastic therapy. Farmacia Hospitalaria, 38(6), 475-481. https://doi.org/10.7399/FH.2014.38.6.8061; Oliveros, C. M. B., Losada, S. M. C., Gutiérrez, N. G., & Sanchez, L. M. (2019). Experiencia y afrontamiento de mujeres con cáncer de mama, mediante la teoría de Callista Roy. Revista Navarra Médica, 5(1), 40-48. https://journals.uninavarra.edu.co/index.php/navarramedica/article/view/195; OMS. (2021, marzo 26). Cáncer de mama. Organización Mundial de la Salud. https://www.who.int/es/news-room/fact-sheets/detail/breast-cancer; wusu, C., Buist, D. S. M., Field, T. S., Lash, T. L., Thwin, S. S., Geiger, A. M., Quinn, V. P., Frost, F., Prout, M., Yood, M. U., Wei, F., & Silliman, R. A. (2008). Predictors of Tamoxifen Discontinuation Among Older Women With Estrogen Receptor–Positive Breast Cancer. Journal of Clinical Oncology, 26(4), 549-555. https://doi.org/10.1200/JCO.2006.10.1022; PAHO & OMS. (2015). Prevención: Factores de riesgo y prevención del cáncer de mama. Organización Panamericana de la Salud. https://www.paho.org/hq/dmdocuments/2015/prevencion-factores-riesgo.pdf; Peng, M.-T., Chen, S.-C., Shen, W.-C., Lin, Y.-C., & Chang, H.-K. (2016). The adherence and tolerance of adjuvant endocrine therapy in geriatric breast cancer patients. Journal of Cancer Research and Practice, 3(3), 69-72. https://doi.org/10.1016/j.jcrpr.2016.05.002; Pistilli, B., Paci, A., Ferreira, A. R., Di Meglio, A., Poinsignon, V., Bardet, A., Menvielle, G., Dumas, A., Pinto, S., Dauchy, S., Fasse, L., Cottu, P. H., Lerebours, F., Coutant, C., Lesur, A., Tredan, O., Soulie, P., Vanlemmens, L., Jouannaud, C., … Vaz-Luis, I. (2020). Serum Detection of Nonadherence to Adjuvant Tamoxifen and Breast Cancer Recurrence Risk. Journal of Clinical Oncology, 38(24), 2762-2772. https://doi.org/10.1200/JCO.19.01758; Quersi, G., Warren, R., & Benson, J. (2015). Cáncer de Mama. Marban Libros. http://www.marbanlibros.mx/muestras/9788416042104/files/basic-html/page4.html; Rivera, E., Fornaris, A., Mariño, E., Díaz, K., Ledesma, R., & Abreu, I. (2019). Factores de riesgo del cáncer de mama en un consultorio de la Atención Primaria de Salud. Revista Habanera de Ciencias Médicas, 18(2), 308-319.; Rivers, A. S., Sanford, K., Elkins, G., Carpenter, J. S., Rand, K. L., & Ellis, R. J. B. (2020). Attitudinal and social predictors of adherence to oral endocrine therapy: A psychometrically-informed model: Journal of Health Psychology, 27(4), 913-922. https://doi.org/10.1177/1359105320982039; Robinson, B., Dijkstra, B., Davey, V., Tomlinson, S., & Frampton, C. (2018). Adherence to Adjuvant Endocrine Therapy in Christchurch Women with Early Breast Cancer. Clinical Oncology, 30(1), e9-e15. https://doi.org/10.1016/j.clon.2017.10.015; Sabadell, M. D., Izquierdo Sanz, M., Prats de Puigs, M., & Modolell Roig, A. (2017). Factores pronósticos y predictivos en cáncer de mama: Una visión evolutiva de la morfología a la genética (8.a ed., Vol. 1). Fundación Española de Senología y Patología Mamaria. https://www.sespm.es/wp-content/uploads/2018/06/MONOGRAFIA-SESPM-2017-Ebook.pdf; Sánchez, E., Sánchez, C., & Erazo, M. (2015). Cáncer de mama: Actualidades y controversias (B. Flores, I. Paiz, A. Delgado, A. Rentería, & J. Paiz, Eds.; 1.a ed., Vol. 1). Editorial Alfil S. A. de C. V. https://bbibliograficas.ucc.edu.co:2280/es/ereader/ucc/117535?page=1; Santiá, P., Jansana, A., del Cura, I., Padilla-Ruiz, M., Domingo, L., Louro, J., Comas, M., Sanz, T., Duarte-Salles, T., Redondo, M., Ibañez, B., Prados-Torres, A., Castells, X., Sala, M., & SURBCAN Group. (2022). Adherence of long-term breast cancer survivors to follow-up care guidelines: A study based on real-world data from the SURBCAN cohort. Breast Cancer Research and Treatment, 193(2), 455-465. https://doi.org/10.1007/s10549-022-06563-x; Santos, L., Barragán, D., Sánchez, L., & Cruz, A. (2020). Resonancia magnética dinámica contrastada en pacientes con recurrencia locorregional de cáncer de mama. Anales de Radiología México, 19(4), 138-145. https://doi.org/10.24875/ARM.20000028; Sheppard, V. B., Sutton, A. L., Hurtado-de-Mendoza, A., He, J., Dahman, B., Edmonds, M. C., Hackney, M. H., & Tadesse, M. G. (2021). Race and Patient-reported Symptoms in Adherence to Adjuvant Endocrine Therapy: A Report from the Women’s Hormonal Initiation and Persistence Study. Cancer Epidemiology, Biomarkers & Prevention, 30(4), 699-709. https://doi.org/10.1158/1055-9965.EPI-20-0604; Silva, J. L. da, Paula, B. H. R. de, Small, I. A., Thuler, L. C. S., & Melo, A. C. de. (2020). Sociodemographic, Clinical, and Pathological Factors Influencing Outcomes in Locally Advanced Triple Negative Breast Cancer: A Brazilian Cohort: Breast Cancer: Basic and Clinical Research, 14(1), 1-12. https://doi.org/10.1177/1178223420962488; Soca, P. E., González, I. A., & González, M. P. (2016). Genetic factors for breast carcinogenesis. Revista Finlay, 6(4), 299-311. https://www.medigraphic.com/pdfs/finlay/fi-2016/fi164g.pdf; Suad, A. K., Bahaaeldin, B., Laila, A. B., & Mahmud, N. (2021). Compliance with Oral Hormonal Therapy for Breast Cancer at Oman National Oncology Center; Descriptive Study. The Gulf journal of oncology, 1(37), 56-61. https://bbibliograficas.ucc.edu.co:2526/35152196/; Teba, V. C. (2015). Cuidados de enfermería en pacientes con cáncer de mama sometidas a radioterapia. Fuandación Dialnet, 20(49), 35-42. https://dialnet.unirioja.es/servlet/articulo?codigo=5408067; Torres, G., & Ángeles, A. (2009). Factores reproductivos y cáncer de mama: Principales hallazgos en América Latina y el mundo. Salud Pública de México, 51(2), 165-169.; Vasquez, L. S. C. (2020). Estilo de vida asociado a cáncer de mama en el Hospital Nacional Luis N. Sáenz, 2019 [Tesis para optar el título profesional de Médico Cirujano, Universidad Ricardo Palma]. http://repositorio.urp.edu.pe/bitstream/handle/URP/2986/LCARRION.pdf?sequence=1&isAllowed=y; Vázquez, C. (2016). Cirugía del cáncer de mama. Técnicas quirúrgicas de tratamiento y de reconstrucción, momento y tiempos de recuperación. Medicina y Seguridad del Trabajo, 62(1), 116-124. https://scielo.isciii.es/pdf/mesetra/v62sextra/ponencias12.pdf; Villarreal-Garza, C., Mesa-Chavez, F., Ferrigno, A., De la Garza-Ramos, C., Fonseca, A., Villanueva-Tamez, K., Campos-Salgado, J. Y., Cruz-Ramos, M., Rodriguez-Gomez, D. O., Ruiz-Cruz, S., & Cabrera-Galeana, P. (2021). Adjuvant endocrine therapy for premenopausal women with breast cancer: Patient adherence and physician prescribing practices in Mexico. The Breast, 59(31), 8-15. https://doi.org/10.1016/j.breast.2021.05.013; Vogsen, M., Bille, C., Jylling, A. M. B., Jensen, M.-B., & Ewertz, M. (2020). Adherence to treatment guidelines and survival in older women with early-stage breast cancer in Denmark 2008–2012. Acta Oncologica, 59(7), 741-747. https://doi.org/10.1080/0284186X.2020.1757148; Wong, F. Y., Wong, R. X., Zhou, S., Ong, W. S., Pek, P. P., Yap, Y.-S., Tan, B. K. T., Ngeow, J. Y. Y., Tan, V. K. M., Sim, Y., Tan, S.-M., Lim, S. H., Madhukumar, P., Tan, T. J. Y., Loh, K. W.-J., Ong, M. E. H., & Wong, T. H. (2021). Effects of housing value and medical subsidy on treatment and outcomes of breast cancer patients in Singapore: A retrospective cohort study. The Lancet Regional Health – Western Pacific, 6(1), 1-11. https://doi.org/10.1016/j.lanwpc.2020.100065; Wuensch, P., Hahne, A., Haidinger, R., Meißler, K., Tenter, B., Stoll, C., Senf, B., & Huebner, J. (2015). Discontinuation and non-adherence to endocrine therapy in breast cancer patients: Is lack of communication the decisive factor? Journal of Cancer Research and Clinical Oncology, 141(1), 55-60. https://doi.org/10.1007/s00432-014-1779-z; Wulaningsih, W., Garmo, H., Ahlgren, J., Holmberg, L., Folkvaljon, Y., Wigertz, A., Van Hemelrijck, M., & Lambe, M. (2018). Determinants of non-adherence to adjuvant endocrine treatment in women with breast cancer: The role of comorbidity. Breast Cancer Research and Treatment, 172(1), 167-177. https://doi.org/10.1007/s10549-018-4890-z; Yussof, I., Mohd Tahir, N. A., Hatah, E., & Mohamed Shah, N. (2022). Factors influencing five-year adherence to adjuvant endocrine therapy in breast cancer patients: A systematic review. The Breast, 62(1), 22-35. https://doi.org/10.1016/j.breast.2022.01.012; Zamora, P. (2019). Hormonoterapia [Sociedad]. seom.org. https://seom.org/163-informacion-al-publico-guia-de-tratamientos/hormonoterapiaRobi; Zhang, H., Ge, X.-Y., & Qiao, H.-Q. (2021). Analysis of prognostic risk factors in 3427 patients with invasive ductal carcinoma of breast: Results based on the SEER database. Asian Journal of Surgery, 44(3), 577-579. https://doi.org/10.1016/j.asjsur.2020.12.014; Zheng, C., & Chagpar, A. B. (2022). Contribution of cost to treatment nonadherence in the US breast cancer survivors: A population-based analysis. Breast Cancer Research and Treatment, 192(2), 369-373. https://doi.org/10.1007/s10549-022-06510-w; https://hdl.handle.net/20.500.12494/47126; López Martínez, A. D. Serrano Ortiz, I. A. Valderrama Sánchez A. S. Gil García. Y. L. (2022). Factores que Interfieren en la Adherencia al Tratamiento Farmacológico en Mujeres Adultas con Cáncer de Seno. [Tesis de pregrado, Universidad Cooperativa de Colombia]. Repositorio Institucional Universidad Cooperativa de Colombia. https://repository.ucc.edu.co/handle/20.500.12494/47126

الاتاحة: https://hdl.handle.net/20.500.12494/47126

المؤلفون: Gil García, Yudith Lorena, Serrano Ortíz, Ivonne Alexandra, López Martínez, Angie Dayanna, Valderrama Sanchez, Angie Stephanie

المساهمون: Contreras Ramos, Luz Mery

المصدر: Ahmed Elsamany, S., Alghanmi, H., Albaradei, A., Abdelhamid, R., Madi, E., & Ramzan, A. (2022). Assessment of compliance with hormonal therapy in early breast cancer patients with positive hormone receptor phenotype: A single institution study. The Breast, 62(1), 69-74. https://doi.org/10.1016/j.breast.2022.01.017 ; Aiello Bowles, E. J., Boudreau, D. M., Chubak, J., Yu, O., Fujii, M., Chestnut, J., & Buist, D. S. M. (2012). Patient-Reported Discontinuation of Endocrine Therapy and Related Adverse Effects Among Women With Early-Stage Breast Cancer. Journal of Oncology Practice, 8(6), e149-e157. https://doi.org/10.1200/JOP.2012.000543 ; American Brain Tumor Association. (2018). Quimioterapia. abta.org. https://www.abta.org/wp-content/uploads/2018/03/quimioterapia.pdf ; American Cancer Society. (2019a). Biopsia ....

مصطلحات موضوعية: Adherencia y Cumplimiento del Tratamiento, Anticarcinógenos, Neoplasia de la Mama, Mujeres, 2022ENF47126, Adherence and compliance to treatment, Anticarcinogens, Breast neoplasia, Women

وصف الملف: 80 p.; application/pdf

Relation: https://repository.ucc.edu.co/handle/20.500.12494/47126; López Martínez, A. D. Serrano Ortiz, I. A. Valderrama Sánchez A. S. Gil García. Y. L. (2022). Factores que Interfieren en la Adherencia al Tratamiento Farmacológico en Mujeres Adultas con Cáncer de Seno. [Tesis de pregrado, Universidad Cooperativa de Colombia]. Repositorio Institucional Universidad Cooperativa de Colombia. https://repository.ucc.edu.co/handle/20.500.12494/47126

الاتاحة: https://repository.ucc.edu.co/handle/20.500.12494/47126
https://hdl.handle.net/20.500.12494/47126